In a world where artificial intelligence is reshaping industries at lightning speed, some entrepreneurs aren’t just kee ...

Macrocyclic peptides are designed to engage complex targets like biologics but pass through cell membranes like small ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

Cancer persists as a leading cause of mortality worldwide, underscoring the urgent need to decipher its molecular complexity for improved detection, ...

Scientists at Shaanxi Normal University have developed an AI-powered dual-channel model that predicts miRNA–drug interactions with up to 96% ...

AI’s perfection cannot capture the imperfections of the human mind -- which touches our souls differently by creating nuanced ...

Given the variability between labs and the unique nature of R&D work, custom, niche AI tools are going to become much more ...

ResearchAndMarkets projects the AI medical diagnostics market to surge to $46.59 billion by 2034, driven by a blistering 33.72% CAGR. Private equity firms believe 2025 could eclipse 2024 as the ...

XtalPi has accrued a number of Big Pharma partners over the years, including Eli Lilly, which struck a $250 million deal in 2023 to use XtalPi’s tech to identify potential drug candidates that Lilly ...